U.S. Branded Generics Market Size & Outlook, 2026-2033

Name: U.S. Branded Generics Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The branded generics market in the United States is expected to reach a projected revenue of US$ 71,824.2 million by 2033. A compound annual growth rate of 5.4% is expected of the United States branded generics market from 2026 to 2033.

Pharmaceuticals
- Metabolic Disorders Treatment
  - Branded Generics Market Outlook

U.S. branded generics route of administration outlook (Revenue, USD million, 2021-2033)
- Topical
- Oral
- Parenteral
- Others Route of Administration
U.S. branded generics application outlook (Revenue, USD million, 2021-2033)
- Neurological Diseases
- Others Application
- Cardiovascular Diseases
- Dermatological diseases
- Oncology
- Gastrointestinal Diseases
- Acute and Chronic Pain
U.S. branded generics drug class outlook (Revenue, USD million, 2021-2033)
- Alkylating Agents
- Hormones
- Others Drug Class
- Anti-hypertensive
- Lipid Lowering drugs
- Anti-psychotics
- Antimetabolites
- Anti-depressants
- Anti-epileptics
U.S. branded generics distribution channel outlook (Revenue, USD million, 2021-2033)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy & Others

U.S. Branded Generics Market Size & Outlook, 2026-2033

Data Tree

Sign up - it's easy, and free!